Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shakila Meshkat

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Translational Psychiatry|February 27, 2025
Increased odds of metabolic syndrome among adults with depressive symptoms or antidepressant useShakila Meshkat, Sophie F Duffy, Vanessa K Tassone, et al.
Plos One|January 17, 2025
Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trialShakila Meshkat, Richard J Zeifman, Kathleen Stewart, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 3, 2025
Mental Health Service Type Use and Depressive Symptoms: A Multivariable Analysis of Sociodemographic Correlates: Utilisation des services de santé mentale et symptômes dépressifs : Analyse multi-variables des corrélats sociodémographiquesShakila Meshkat, Qiaowei Lin, Vanessa K Tassone, et al.
Bjpsych Open|November 5, 2024
Gender differences in the relationship between depressive symptoms and diabetes associated with cognitive-affective symptomsShakila Meshkat, Vanessa K Tassone, Sarah Dunnett, et al.
Behavioural Neurology|September 23, 2020
Evaluating Executive Functions in Patients with Juvenile Myoclonic Epilepsy Using Frontal Assessment BatteryHossein Sanjari Moghaddam, Masoud Doost Hoseini, Mohammad Reza Khaleghi, et al.
Journal of Psychiatric Research|March 18, 2022
The effects of psychostimulants on cognitive functions in individuals with attention-deficit hyperactivity disorder: A systematic reviewAndrea Mckenzie, Shakila Meshkat, Leanna M W Lui, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|March 25, 2024
Does Self-Reported BMI Modify the Association Between Stroke and Depressive Symptoms?Shakila Meshkat, Vanessa K Tassone, Michelle Wu, et al.
Psychiatry Research|August 20, 2025
Real world effectiveness of maintenance ketamine infusions for treatment-resistant depression in major depressive disorder and bipolar disorderSipan Haikazian, Roger S McIntyre, Shakila Meshkat, et al.
Plos One|February 11, 2026
Life stressors and mental health: Depressive symptoms, anxiety, and suicidal ideation or intent during and after the COVID-19 pandemicShakila Meshkat, Xiaoxuan Han, Qiaowei Lin, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|January 18, 2023
Oral ketamine for depression: An updated systematic reviewShakila Meshkat, Sipan Haikazian, Joshua D Di Vincenzo, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Translational Psychiatry|February 27, 2025
Increased odds of metabolic syndrome among adults with depressive symptoms or antidepressant useShakila Meshkat, Sophie F Duffy, Vanessa K Tassone, et al.
Plos One|January 17, 2025
Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trialShakila Meshkat, Richard J Zeifman, Kathleen Stewart, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|June 3, 2025
Mental Health Service Type Use and Depressive Symptoms: A Multivariable Analysis of Sociodemographic Correlates: Utilisation des services de santé mentale et symptômes dépressifs : Analyse multi-variables des corrélats sociodémographiquesShakila Meshkat, Qiaowei Lin, Vanessa K Tassone, et al.
Bjpsych Open|November 5, 2024
Gender differences in the relationship between depressive symptoms and diabetes associated with cognitive-affective symptomsShakila Meshkat, Vanessa K Tassone, Sarah Dunnett, et al.
Behavioural Neurology|September 23, 2020
Evaluating Executive Functions in Patients with Juvenile Myoclonic Epilepsy Using Frontal Assessment BatteryHossein Sanjari Moghaddam, Masoud Doost Hoseini, Mohammad Reza Khaleghi, et al.
Journal of Psychiatric Research|March 18, 2022
The effects of psychostimulants on cognitive functions in individuals with attention-deficit hyperactivity disorder: A systematic reviewAndrea Mckenzie, Shakila Meshkat, Leanna M W Lui, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|March 25, 2024
Does Self-Reported BMI Modify the Association Between Stroke and Depressive Symptoms?Shakila Meshkat, Vanessa K Tassone, Michelle Wu, et al.
Psychiatry Research|August 20, 2025
Real world effectiveness of maintenance ketamine infusions for treatment-resistant depression in major depressive disorder and bipolar disorderSipan Haikazian, Roger S McIntyre, Shakila Meshkat, et al.
Plos One|February 11, 2026
Life stressors and mental health: Depressive symptoms, anxiety, and suicidal ideation or intent during and after the COVID-19 pandemicShakila Meshkat, Xiaoxuan Han, Qiaowei Lin, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|January 18, 2023
Oral ketamine for depression: An updated systematic reviewShakila Meshkat, Sipan Haikazian, Joshua D Di Vincenzo, et al.
Pageof 9